Publications
- Biolo, A, R Greferath, DA Siwik, F Qin, E Valsky, KC Fylaktakidou, S Pothukanuri, CD Duarte, RP Schwarz, JM Lehn, C Nicolau, and WS Colucci. (2009) Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of haemoglobin, myo-inositol trispyrophosphate. Proc Natl Acad Sci. USA 106:1926-1929.
- Sihn, G, T Walter, JC Klein, I Queguiner, H Iwao, C Nicolau, JM Lehn, P Corvol, and JM Gasc. (2007) Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma. FEBS Letters. 581:962-966.
- Kieda, C, R Greferath, C Crola Da Silva, KC Fylaktakidou, JM Lehn, and C Nicolau. (2006) Suppression of hypoxia-induced HIF-1α and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes. Proc Natl Acad Sci. USA 103:15576-15581.
- Fylaktakidou, KC, JM Lehn, R Greferath, and C Nicolau. (2005) Inositol tripyrophosphate: a new membrane permeant allosteric effector of haemoglobin. Bioorganic & Medicinal Chemistry Letters. 15:1605-1608.
- Vincent, SP, JM Lehn, J Lazarte, and C Nicolau. (2002) Transport of the highly charged myo-inositol hexakisphosphate molecule across the red blood cell membrane: A phase transfer and biological study. Bioorganic and Medicinal Chemistry. 10:2825-2834.
- Teisseire, BP, C Ropars, MO Vallez, RA Herigault, and C Nicolau. (1985) Physiological effects of high P50- erythrocyte transfusion on piglets. Journal of Applied Physiology. 58:1810-1817.
- Teisseire, B, C Ropars, MC Villeareal, and C Nicolau. (1987) Long-term physiological effects of enhanced O2 release by inositol hexaphosphate-loaded erythrocytes. Proc Natl Acad Sci. USA 84:6894-6898.